Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
基本信息
- 批准号:8496611
- 负责人:
- 金额:$ 19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AfricanAntimalarialsAreaBiologyBiotechnologyCameroonCentral AfricaChildClinical Trials DesignCommunicable DiseasesCountryDiagnostic testsDiseaseDoctor of PhilosophyDrug KineticsDrug resistanceEducational workshopEvolutionFacultyFetal DevelopmentFlow CytometryGoalsGrantHealth ResourcesHealthcareImmunologyInfantInfectionInsecticidesMalariaMaternal and Child HealthMeasuresMentorsMonitorNewborn InfantParasitesPharmaceutical PreparationsPhysiciansPlacentaPlasmodium falciparumPostdoctoral FellowPregnant WomenPrevalencePublic HealthResearchResearch TrainingResidenciesScientistStudentsTimeTrainingTraining ActivityTraining ProgramsUltrasonographyUnited States National Institutes of HealthUniversitiesdesignhigh riskimprovedmemberprogramsskillsvector
项目摘要
ABSTRACT
Malaria, caused by Plasmodium falciparum, is one of the three major infectious diseases in the
world today. The introduction of control measures including insecticide-treated bednets, rapid
diagnostic tests, and intermittent preventative treatment (IPT) have reduced the prevalence of
malaria in a number of African countries, yet malaria remains highly endemic in central Africa
where public health resources are poor. At highest risk of severe infections are pregnant women
and young children. More than ever, well-trained African scientists are needed to monitor the
changing landscape as the malaria picture rapidly changes. Scientists in Cameroon are actively
engage in research on malaria, but additional expertise and faculty are needed to identify malaria-
related problems as they arise and design strategies to solve them. Therefore, the purpose of this
application is to help young Cameroonian scientists acquired the skills necessary for conducting
research on malaria, with a focus on malaria in pregnant women and infants. In 1994, scientists
at the University of Yaound¿ 1, Cameroon, and Georgetown University began collaborating on
malaria at the Biotechnology Center (BTC). Through continuous NIH grant support and a training
grant from the Maternal and Child Health Research Training Program (MCHRT), a group of 5 full-
time faculty members, >6 well-trained technicians, and ~40 students are conducting research at
the BTC. Previous trainees wish to return after completing their post-doctoral and residency
programs in the USA. This application proposes ways to help the malaria group at the BTC
acquire the critical mass and expertise it needs to develop a long-term sustainable research
program on malaria. The specific goal of the application is to provide expertises that is currently
lacking at the BTC that would supplement on-going research. Areas of training include 1) use of
anti-malarial drugs (pharmacokinetics, evolution of parasite-drug resistance, and clinical trial
design), 2) immunology of the placenta, with emphasis on flow cytometry, 3) co-infections
between malaria and other diseases, 4) use of ultrasound for monitoring fetal development, and 5)
vector biology. The program includes training of 3 PhD-level and 4 MS-level students, mentoring
of returning clinicians(s) in OB/GYN and infectious diseases, and training of local physicians in
ultrasound. Three in-country workshops designed and conducted by former FIC trainees are
proposed. These training activities will significantly contribute to the long-term goal of creating a
group of scientists at the BTC whose research will continue to improve the health care of pregnant
women and their newborns.
抽象的
疟疾是由恶性疟原虫引起的,是世界三大传染病之一。
当今世界。采取控制措施,包括使用经过杀虫剂处理的蚊帐、快速
诊断测试和间歇性预防性治疗(IPT)已降低了患病率
一些非洲国家存在疟疾,但中部非洲疟疾仍然高度流行
公共卫生资源匮乏的地方。严重感染的风险最高的是孕妇
和幼儿。比以往任何时候都更需要训练有素的非洲科学家来监测
随着疟疾情况的迅速变化,情况也在发生变化。喀麦隆科学家正在积极
参与疟疾研究,但需要更多的专业知识和教师来识别疟疾
当相关问题出现时,并设计解决这些问题的策略。因此,本次活动的目的
申请的目的是帮助年轻的喀麦隆科学家获得进行研究所需的技能
疟疾研究,重点关注孕妇和婴儿的疟疾。 1994年,科学家
喀麦隆雅温得大学和乔治敦大学开始合作
生物技术中心(BTC)的疟疾。通过持续的 NIH 拨款支持和培训
来自妇幼健康研究培训计划 (MCHRT) 的拨款,该计划由 5 名全职人员组成
time 的教职人员、超过 6 名训练有素的技术人员和约 40 名学生正在
比特币。以前的学员希望在完成博士后和住院医师实习后返回
美国的项目。该应用程序提出了帮助 BTC 疟疾小组的方法
获得开展长期可持续研究所需的临界质量和专业知识
疟疾计划。该应用程序的具体目标是提供当前的专业知识
缺乏可以补充正在进行的研究的 BTC。培训领域包括 1) 使用
抗疟疾药物(药代动力学、寄生虫耐药性的演变和临床试验
设计),2)胎盘免疫学,重点是流式细胞术,3)合并感染
疟疾和其他疾病之间的关系,4) 使用超声波监测胎儿发育,以及 5)
矢量生物学。该计划包括培训 3 名博士级学生和 4 名硕士级学生、指导
妇产科和传染病领域的回国临床医生,以及当地医生的培训
超声波。由前 FIC 学员设计和举办的三个国内研讨会是
建议的。这些培训活动将极大地有助于实现创建一个
BTC 的科学家小组,他们的研究将继续改善孕妇的医疗保健
妇女及其新生儿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diane Wallace Taylor其他文献
Diane Wallace Taylor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diane Wallace Taylor', 18)}}的其他基金
Immunity to Placental Malaria: Persistence of Antibodies to VAR2CSA
对胎盘疟疾的免疫力:VAR2CSA 抗体的持久性
- 批准号:
8989517 - 财政年份:2014
- 资助金额:
$ 19万 - 项目类别:
Immunity to Placental Malaria: Persistence of Antibodies to VAR2CSA
对胎盘疟疾的免疫力:VAR2CSA 抗体的持久性
- 批准号:
8823392 - 财政年份:2014
- 资助金额:
$ 19万 - 项目类别:
Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
- 批准号:
8182903 - 财政年份:2011
- 资助金额:
$ 19万 - 项目类别:
Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
- 批准号:
8305507 - 财政年份:2011
- 资助金额:
$ 19万 - 项目类别:
Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
- 批准号:
8710368 - 财政年份:2011
- 资助金额:
$ 19万 - 项目类别:
相似海外基金
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
- 批准号:
MR/X030202/1 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Research Grant
Novel Dual-Stage Antimalarials: Machine learning prediction, validation and evolution
新型双阶段抗疟药:机器学习预测、验证和进化
- 批准号:
10742205 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Natural Product Inspired Novel Antimalarials with Radical Cure Potential
受天然产物启发的具有根治潜力的新型抗疟药
- 批准号:
10635649 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10534667 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Plasmodium Protein Kinase Focused Antimalarials Discovery
疟原虫蛋白激酶聚焦抗疟药的发现
- 批准号:
10533634 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Development of new lead antimalarials targeting parasite coenzyme A biosynthesis and utilisation.
开发针对寄生虫辅酶 A 生物合成和利用的新型先导抗疟药。
- 批准号:
468862 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Operating Grants
DMPK Optimisation of B-hydroxyethylamine Antimalarials
B-羟乙胺抗疟药的 DMPK 优化
- 批准号:
2749037 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Studentship
Repurposing antimalarials for the treatment of NTM infections
重新利用抗疟药治疗 NTM 感染
- 批准号:
10646331 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10368441 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Plasmodium Protein Kinase Focused Antimalarials Discovery
疟原虫蛋白激酶聚焦抗疟药的发现
- 批准号:
10663334 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:














{{item.name}}会员




